Last edition
News about "SEZ-II in Ahmedabad"
Zydus Lifesciences' Ahmedabad Manufacturing Plant Clears US FDA Inspection with Zero Observations
The inspection, which took place from 11 to 13 August 2025, evaluated three products under general current Good Manufacturing Practice (cGMP) standards and concluded without any regulatory findings or compliance issues.
SEZ-II In Ahmedabad | 18/08/2025 | By Darshana | 202
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members